Assessment of the Tolerability and Efficacy of Amlodipine in 9295 Patients with Mild or Moderate Essential Hypertension

被引:0
|
作者
A. C. Pessina
M. Gallucci
机构
[1] University of Padua,Institute of Clinical Medicine
[2] Hospital S. Giovanni,Department of Angiology
来源
关键词
Diastolic Blood Pressure; Calcium Antagonist; Amlodipine; Antihypertensive Agent; Drug Invest;
D O I
暂无
中图分类号
学科分类号
摘要
An open multicentre study was conducted to evaluate the long term efficacy and tolerability of once-daily amlodipine (5 or 10mg for up to 24 weeks) in 9295 patients with mild or moderate essential hypertension. After a 2-week washout period, patients began treatment with amlodipine 5 mg/day, and this could be increased to 10 mg/day in patients showing inadequate blood pressure control after 2 weeks. If acceptable control was not achieved after 6 weeks of treatment with amlodipine alone, a second antihypertensive agent could be added (diuretic, ACE inhibitor or β-blocker). Data were analysed for the population as a whole, as well as for 2 subgroups based on age (group I: ≤ 65 years; group II: > 65 years).
引用
下载
收藏
页码:137 / 142
页数:5
相关论文
共 50 条
  • [21] Efficacy, tolerability and influence on "quality of life" of nifedipine GITS versus amlodipine in elderly patients with mild-moderate hypertension
    Pessina, AC
    Boari, L
    De Dominicis, E
    Giusti, C
    Marchesi, M
    Marelli, G
    Mattarei, M
    Mos, L
    Novo, S
    Pirrelli, A
    Santini, M
    Santonastaso, M
    Semeraro, S
    Uslenghi, E
    Kilama, MO
    BLOOD PRESSURE, 2001, 10 (03) : 176 - 183
  • [22] Relative efficacy and tolerability of lacidipine and amlodipine in patients with mild-to-moderate hypertension: A randomized double-blind study
    Lau, CP
    Cheung, BMY
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (02) : 328 - 331
  • [23] EFFICACY AND SAFETY OF OLMESARTAN AND OLMESARTAN PLUS HYDROCHLOROTHIAZIDE COMBINED WITH AMLODIPINE IN CHINESE PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION
    Li Hongwei
    Mei Kezhi
    Hua Qi
    Dai Qiuyan
    Peng Xiaoling
    Ding Hong
    Pi Lin
    Jin Zhimin
    Zhang Daifu
    Lv Ke
    Guo Xingui
    Xu Hui
    You Hua
    Yin Pengfei
    Yu Licheng
    Yang Ming
    Yu Xiaowei
    Naotaka, Ikegami
    Zhou Shuxian
    Gao Pingjin
    HEART, 2013, 99 : A61 - A62
  • [24] Efficacy and tolerability of valsartan in outdoor patients with mild to moderate hypertension and hyperlipoproteinemia
    Werner, J
    Zilka, V
    JOURNAL OF HYPERTENSION, 2002, 20 : S401 - S401
  • [25] ASSESSMENT OF EFFICACY, SAFETY, AND TOLERABILITY OF ENALAPRIL MALEATE VERSUS NIFEDIPINE IN THE THERAPY OF MILD AND MODERATE ESSENTIAL-HYPERTENSION
    PLAVNICK, FL
    MARSON, O
    RODRIGUES, CIS
    NEVES, FAR
    PAULA, RB
    KOHLMANN, O
    RIBEIRO, AB
    REVISTA BRASILEIRA DE MEDICINA, 1990, 47 (1-2) : 49 - 52
  • [26] AMLODIPINE IN THE TREATMENT OF MILD-TO-MODERATE ESSENTIAL-HYPERTENSION
    ESIN, RA
    ESSIEN, OE
    ANDY, J
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1994, 55 (09): : 1112 - 1116
  • [27] AMBULATORY BLOOD PRESSURE LOWERING EFFICACY AND TOLERABILITY OF INITIAL HIGH DOSE OF AMLODIPINE IN MILD OR MODERATE HYPERTENSION
    Chen, Qi
    Kang, Yuanyuan
    Li, Yan
    Wang, Jiguang
    JOURNAL OF HYPERTENSION, 2016, 34 : E443 - E443
  • [28] THE EFFICACY AND TOLERABILITY OF AMLODIPINE AND HYDROCHLOROTHIAZIDE IN NIGERIANS WITH ESSENTIAL-HYPERTENSION
    AJAYI, AA
    AKINTOMIDE, AO
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 1995, 87 (07) : 485 - 488
  • [29] Effects of amlodipine and candesartan on oxidized LDL level in patients with mild to moderate essential hypertension
    Muda, Piibe
    Kampus, Priit
    Teesalu, Rein
    Zilmer, Kersti
    Ristimae, Tiina
    Fischer, Krista
    Zilmer, Mihkel
    BLOOD PRESSURE, 2006, 15 (05) : 313 - 318
  • [30] EFFICACY AND TOLERABILITY OF ENALAPRIL AND SUSTAINED-RELEASE VERAPAMIL IN OLDER PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION
    WEIR, MR
    CASSIDY, CA
    HALL, PS
    LANCASTER, A
    SCHUBERT, C
    URICK, A
    SAUNDERS, E
    KONG, BW
    JENKINS, P
    LAVIN, PT
    CLINICAL THERAPEUTICS, 1990, 12 (02) : 139 - 148